{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:15Z","timestamp":1793377875331,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["217112\/Z\/19\/Z"],"award-info":[{"award-number":["217112\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["220863"],"award-info":[{"award-number":["220863"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["214344"],"award-info":[{"award-number":["214344"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["ID2020\/100020"],"award-info":[{"award-number":["ID2020\/100020"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S023380r thar\/1"],"award-info":[{"award-number":["MR\/S023380r thar\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.056","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:37:33Z","timestamp":1785800253000},"page":"5763-5782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3"],"prefix":"10.1016","volume":"34","author":[{"given":"Dara","family":"Annett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan J.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-3410","authenticated-orcid":false,"given":"Kate L.","family":"Morling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0997-9628","authenticated-orcid":false,"given":"Valeria","family":"Pingitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Kurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Warne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefta E.","family":"Moula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Le\u00f3n-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihansu","family":"Kuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Toros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnim","family":"Nurullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew V.X.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W. Edith","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.B.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia S.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy G.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Selwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-0264","authenticated-orcid":false,"given":"Greg J.","family":"Towers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.056_bib1","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-022-00800-6","article-title":"Gene therapy for inborn errors of immunity: past, present and future","volume":"23","author":"Fischer","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.07.056_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2026.07.056_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","article-title":"Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for Wiskott\u2013Aldrich syndrome","volume":"28","author":"Magnani","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib8","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/s41467-025-60073-0","article-title":"Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes","volume":"16","author":"Canepari","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.056_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41586-025-09070-3","article-title":"In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking","volume":"643","author":"Milani","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.056_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/hum.2019.132","article-title":"Dual ABCA4-AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease","volume":"30","author":"Dyka","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.gt.3301574","article-title":"In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium","volume":"8","author":"Bainbridge","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib12","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1167\/iovs.13-11871","article-title":"Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease","volume":"54","author":"Binley","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.07.056_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1006\/mthe.2002.0690","article-title":"Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat","volume":"6","author":"Duisit","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/gt.2014.57","article-title":"Retinal transduction profiles by high-capacity viral vectors","volume":"21","author":"Puppo","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/104303402317322258","article-title":"Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors","volume":"13","author":"Lotery","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib16","first-page":"5210","article-title":"Correction of the Disease Phenotype in the Mouse Model of Stargardt Disease by Lentiviral Gene Therapy","volume":"46","author":"Kong","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.07.056_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jgm.845","article-title":"Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors","volume":"8","author":"Balaggan","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood-2013-12-546218","article-title":"Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.056_bib19","doi-asserted-by":"crossref","first-page":"E10069","DOI":"10.1073\/pnas.1811892115","article-title":"mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3","volume":"115","author":"Shi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.056_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.stem.2018.10.008","article-title":"Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells","volume":"23","author":"Petrillo","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.07.056_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/blood.2019000040","article-title":"Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes","volume":"134","author":"Ozog","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.056_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.056_bib23","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","article-title":"IFITMs Restrict the Replication of Multiple Pathogenic Viruses","volume":"425","author":"Perreira","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/cmi.12262","article-title":"Identification of an endocytic signal essential for the antiviral action of IFITM3","volume":"16","author":"Jia","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.07.056_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004048","article-title":"IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion","volume":"10","author":"Desai","year":"2014","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.056_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.056_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.543444","article-title":"Current Progress on Host Antiviral Factor IFITMs","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41589-018-0213-2","article-title":"IFITM3 directly engages and shuttles incoming virus particles to lysosomes","volume":"15","author":"Spence","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/1753425912443392","article-title":"Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function","volume":"18","author":"Wee","year":"2012","journal-title":"Innate Immun."},{"key":"10.1016\/j.ymthe.2026.07.056_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mt.2014.193","article-title":"Cyclosporin A and Rapamycin Relieve Distinct Lentiviral Restriction Blocks in Hematopoietic Stem and Progenitor Cells","volume":"23","author":"Petrillo","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.056_bib32","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41564-019-0592-5","article-title":"Cyclophilin A protects HIV-1 from restriction by human TRIM5\u03b1","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.chom.2018.10.007","article-title":"Trivalent RING Assembly on Retroviral Capsids Activates TRIM5 Ubiquitination and Innate Immune Signaling","volume":"24","author":"Fletcher","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.07.056_bib34","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.15252\/embj.201490361","article-title":"TRIM5\u03b1 requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription","volume":"34","author":"Fletcher","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.07.056_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature09976","article-title":"TRIM5 is an innate immune sensor for the retrovirus capsid lattice","volume":"472","author":"Pertel","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.056_bib36","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1073\/pnas.1516920112","article-title":"Dynamic allostery governs cyclophilin A\u2013HIV capsid interplay","volume":"112","author":"Lu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.056_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002439","article-title":"HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency","volume":"7","author":"Schaller","year":"2011","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.056_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tim.2023.07.003","article-title":"Molecular frustration: a hypothesis for regulation of viral infections","volume":"32","author":"Twarock","year":"2024","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib39","first-page":"28","article-title":"Chemistry of the natural cyclosporin metabolites","volume":"38","author":"von Wartburg","year":"1986","journal-title":"Prog. Allergy"},{"key":"10.1016\/j.ymthe.2026.07.056_bib40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hlca.19820650538","article-title":"Isolierung und Strukturermittlung der neuen Cyclosporine E, F, G, H und I","volume":"65","author":"Traber","year":"1982","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ymthe.2026.07.056_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0166-0934(89)90132-8","article-title":"Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy","volume":"23","author":"Cornetta","year":"1989","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ymthe.2026.07.056_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/hgtb.2017.085","article-title":"Improving Lentiviral Transduction of CD34+ Hematopoietic Stem and Progenitor Cells","volume":"29","author":"Hauber","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2026.07.056_bib43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.056_bib44","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1074\/jbc.M115.700385","article-title":"Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis","volume":"291","author":"Warne","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.056_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/jmbi.1998.2108","article-title":"X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A1","volume":"283","author":"Kallen","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib46","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/BJ20111301","article-title":"A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes","volume":"441","author":"Dube","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2026.07.056_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature12769","article-title":"HIV-1 evades innate immune recognition through specific co-factor recruitment","volume":"503","author":"Rasaiyaah","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.056_bib48","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1073\/pnas.0402474101","article-title":"The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities","volume":"101","author":"Keckesova","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.056_bib49","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.056_bib50","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/ijms20163859","article-title":"Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay","volume":"20","author":"Winkler","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.07.056_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02003-18","article-title":"Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane","volume":"93","author":"Smith","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/pathogens12040519","article-title":"Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity","volume":"12","author":"Meischel","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2026.07.056_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature12653","article-title":"MX2 is an interferon-induced inhibitor of HIV-1 infection","volume":"502","author":"Kane","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.056_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2017.11.018","article-title":"Intrinsic Immunity Shapes Viral Resistance of Stem Cells","volume":"172","author":"Wu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.056_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2019.05.015","article-title":"Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application","volume":"14","author":"Schott","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.056_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160766","article-title":"Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2","volume":"132","author":"Shi","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.07.056_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2022.02.013","article-title":"Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I\/IIa Clinical Trial, Cohorts 1-5","volume":"240","author":"Parker","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib58","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.07.056_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jgm.2653","article-title":"Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors","volume":"14","author":"H\u00f6fig","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.07.056_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167759","article-title":"Cholesterol Binds the Amphipathic Helix of IFITM3 and Regulates Antiviral Activity","volume":"434","author":"Rahman","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib61","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.micinf.2004.05.002","article-title":"Endocytosis of influenza viruses","volume":"6","author":"Lakadamyali","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2026.07.056_bib62","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1128\/JVI.76.20.10455-10464.2002","article-title":"Influenza Virus Can Enter and Infect Cells in the Absence of Clathrin-Mediated Endocytosis","volume":"76","author":"Sieczkarski","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2024.03.003","article-title":"Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia","volume":"154","author":"Bahal","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.056_bib66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.07.056_bib67","doi-asserted-by":"crossref","DOI":"10.1242\/dev.157511","article-title":"Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent manner","volume":"145","author":"Cristante","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2026.07.056_bib68","article-title":"Cyclosporine analogues","author":"Towers","year":"2023","journal-title":"Patent Assignee UCL BUSINESS LTD. Gb, WO 2023\/247937 A1"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:34:12Z","timestamp":1793374452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006799"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.056","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}